Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports
Authors' conclusion
This prospective study demonstrates the safety of resuming elite-level sports after SARS-CoV-2 infection.
Study context
- Population
- Elite athletes (mean age 26±5 years; 40% women) from the ELITE cohort
- Participants
- 259 athletes
- Exposure
- SARS-CoV-2-infected vs non-infected elite athletes
- Infectedn = 123
- Controlsn = 136reference
- Outcome
- Long-term detrimental cardiac effects: ventricular volumes and function, LGE and T1 on CMR; cardiac adverse events, ventricular arrhythmia burden, cessation of sports careers
Main finding
As reported in the abstract
| Group | Value | Late gadolinium enhancement (LGE) |
|---|---|---|
| Infected | 3% | 4 (3%), one reversible |
| Controls | 0 events | none |
Value
Infected3%
Controls0 events
Late gadolinium enhancement (LGE)
Infected4 (3%), one reversible
Controlsnone
Observational data: associations, not effects.
Further findings
- Follow-up of infected athletes · 26.7 (±5.8) months
- 96% · 118 of 123
Follow-up of infected athletes · 26.7 (±5.8) months
- All 4 athletes with LGE resumed elite-level sports without increase in ventricular arrhythmias or adverse cardiac remodelling
- No sports careers terminated due to SARS-CoV-2
Safety
- New cardiac symptoms or events (infected athletes) · 26.7 (±5.8) months
- 0 · events
- New cardiac symptoms or events (infected athletes) — None of the infected athletes reported new cardiac symptoms or events
- 0
Original publication
Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports. Heart. Published 7 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →